Drug Recalls

Drug Recalls: Is Avandia Next?

On July 16, 2010, the Food and Drug Administration (FDA) decided to keep the diabetes drug Avandia (rosiglitazone) on the market despite a cardiovascular threat to some patients. Conflicting studies have shown that the drug rosiglitazone promotes increased cardiovascular risk to patients with diabetes. The FDA, as well as the Endocrine Society, the American Association of Clinical Endocrinologists and the American Diabetes Association, have issued warnings that stopping the...
Read More

Product Liability Claim Involving Pharmaceutical Drugs

As part of our emphasis on client education, our California defective drugs attorneys would like you to know that while each defective drug and product liability case is unique, pharmaceutical product liability claims fall under three categories: Defectively manufactured drugs This type of claim includes people who have suffered an injury due to pharmaceuticals that are contaminated, were not manufactured properly or both. Drugs with dangerous side effects These...
Read More

Ranbaxy Announces Recall of Antibiotic in U.S.

On the heels of a recall of one lot of their skin care product, pharmaceutical manufacturer Ranbaxy Pharmaceuticals, Inc. has also announced that they are voluntarily recalling two lots of the antibiotic drug from the U.S. market. Drug maker Ranbaxy recently recalled one lot of their 40 milligram Sotret Isotretinoin capsules, a drug that can help acne sufferers have cleaner skin. The company’s second recall involves Lots No 1910779...
Read More

FDA Warning Causes Hospira to Issue Recall for the Second Time in Six Months

Drug maker Hospira, Inc. has issued a recall for two of its drugs for the second time in six months due to manufacturing defects. The U.S. Food and Drug Administration recently issued a warning about the defects, prompting the manufacturer to recall Propofol and Liposyn. Propofol, an anesthetic, and Liposyn, an intravenous nutritional product, were recalled April 1. Hospira told the FDA that these two pharmaceuticals had been contaminated...
Read More

Drug Company Issues Voluntary Recall of Drug

Prescription drug manufacturer American Regent has issued a voluntary recall of every lot of their ketorolac tromethamine injection, 30 mg/ml product. The US Food and Drug Administration (FDA) announced recently that particulate matter and crystallization might be present in the drug that could result in obstruction of blood vessels. If a person injects the drug and particulate matter and crystallization is present, it could induce pulmonary emboli or thrombosis...
Read More

Children’s Tylenol Recalled

This Newsday article claims that the McNeil unit of Johnson & Johnson has voluntarily recalled 57 lots of infants and children’s liquid Tylenol products due to the possibility of bacterial contamination. The Tylenol products manufactured between April and June 2009 included almost two dozen varieties subject to the recall. Johnson & Johnson has said publicly that an inactive ingredient in the various types of product did not meet the...
Read More

VIOXX® Class Action Suits Suffer Setback in California Courts

In a statement released on Pharmaceutical Online, Los Angeles Superior Court Judge Victoria Chaney struck down a request to certify a class of consumers and insurers seeking reimbursement from drug manufacturer Merck over costs of VIOXX®. The ruling dashes the hopes of plaintiffs and insurance companies who sought the ability to conduct class-action suits seeking compensation for the pain medication’s tendency to increase the risk of heart attacks or...
Read More

FDA Recalls Hydroxycut

The United States Food and Drug Administration (FDA) has officially warned consumers to discontinue using the popular weight loss product, Hydroxycut. In a press release issued May 1, 2009, the FDA made the warning about the product after receiving numerous reports of serious liver damage among those using the dietary supplement products. As of the time of the recall announcement, Hydroxycut has been involved in at least one death...
Read More